CARD17 anticorps (AA 1-100) (Cy5)
Aperçu rapide pour CARD17 anticorps (AA 1-100) (Cy5) (ABIN886429)
Antigène
Voir toutes CARD17 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-100
-
Homologie
- Human
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CARD17/INCA
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))
-
Autre désignation
- CARD17
-
Sujet
-
Synonyms: CAR17_HUMAN, CARD 17, CARD17, Caspase 1 inhibitor, Caspase recruitment domain containing protein 17, Caspase recruitment domain-containing protein 17, Caspase-1 inhibitor INCA, Caspase1 inhibitor, Inhibitory caspase recruitment domain CARD protein, Inhibitory caspase recruitment domain protein.
Background: Regulator of procaspase-1/CASP1 activation implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. Inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, do not induce NF-kappa-B activation.
Antigène
-